Northern Trust’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.1M Sell
312,555
-6,857
-2% -$654K ﹤0.01% 1357
2025
Q4
$25.9M Sell
319,412
-17,388
-5% -$1.5M ﹤0.01% 1502
2025
Q3
$29.5M Sell
336,800
-6,383
-2% -$570K ﹤0.01% 1447
2025
Q2
$28.5M Sell
343,183
-2,380
-0.7% -$199K ﹤0.01% 1440
2025
Q1
$29M Buy
345,563
+17,748
+5% +$1.65M ﹤0.01% 1408
2024
Q4
$30.2M Buy
327,815
+15,843
+5% +$1.52M ﹤0.01% 1442
2024
Q3
$29M Buy
311,972
+7,267
+2% +$630K ﹤0.01% 1395
2024
Q2
$25.1M Sell
304,705
-9,184
-3% -$675K ﹤0.01% 1417
2024
Q1
$20.8M Buy
313,889
+4,927
+2% +$304K ﹤0.01% 1569
2023
Q4
$17.5M Buy
308,962
+3,519
+1% +$184K ﹤0.01% 1709
2023
Q3
$16.6M Buy
305,443
+10,548
+4% +$625K ﹤0.01% 1674
2023
Q2
$19.8M Buy
294,895
+7,128
+2% +$435K ﹤0.01% 1589
2023
Q1
$14.8M Buy
287,767
+2,795
+1% +$136K ﹤0.01% 1752
2022
Q4
$13.1M Buy
284,972
+8,799
+3% +$412K ﹤0.01% 1825
2022
Q3
$14M Sell
276,173
-2,785
-1% -$139K ﹤0.01% 1738
2022
Q2
$12.7M Buy
278,958
+326
+0.1% +$14.6K ﹤0.01% 1847
2022
Q1
$12.9M Sell
278,632
-1,525
-0.5% -$68.2K ﹤0.01% 1986
2021
Q4
$14.1M Sell
280,157
-1,563
-0.6% -$80.8K ﹤0.01% 2006
2021
Q3
$15M Buy
281,720
+8,348
+3% +$470K ﹤0.01% 1999
2021
Q2
$16.7M Buy
273,372
+1,695
+0.6% +$90K ﹤0.01% 2017
2021
Q1
$13.3M Sell
271,677
-21,165
-7% -$992K ﹤0.01% 2103
2020
Q4
$11.9M Sell
292,842
-2,626
-0.9% -$93.9K ﹤0.01% 2147
2020
Q3
$9.61M Buy
295,468
+439
+0.1% +$13.2K ﹤0.01% 2130
2020
Q2
$7.79M Buy
295,029
+1,732
+0.6% +$45.3K ﹤0.01% 2256
2020
Q1
$7.31M Buy
293,297
+4,564
+2% +$141K ﹤0.01% 2085
2019
Q4
$10.4M Buy
288,733
+4,074
+1% +$141K ﹤0.01% 2160
2019
Q3
$9.73M Buy
284,659
+19,866
+8% +$635K ﹤0.01% 2162
2019
Q2
$7.41M Buy
264,793
+1,345
+0.5% +$37.4K ﹤0.01% 2334
2019
Q1
$8.17M Sell
263,448
-2,146
-0.8% -$57.3K ﹤0.01% 2283
2018
Q4
$6.28M Sell
265,594
-10,276
-4% -$281K ﹤0.01% 2364
2018
Q3
$10.7M Buy
275,870
+18,919
+7% +$682K ﹤0.01% 2218
2018
Q2
$8.6M Buy
256,951
+7,700
+3% +$274K ﹤0.01% 2363
2018
Q1
$9.03M Buy
249,251
+4,465
+2% +$155K ﹤0.01% 2236
2017
Q4
$7.79M Buy
244,786
+36
+0% +$1.23K ﹤0.01% 2347
2017
Q3
$9.16M Buy
244,750
+5,079
+2% +$173K ﹤0.01% 2256
2017
Q2
$7.48M Buy
239,671
+21,473
+10% +$620K ﹤0.01% 2353
2017
Q1
$5.37M Buy
218,198
+17,424
+9% +$409K ﹤0.01% 2520
2016
Q4
$5.09M Sell
200,774
-6,303
-3% -$140K ﹤0.01% 2539
2016
Q3
$4.11M Buy
207,077
+19,104
+10% +$334K ﹤0.01% 2639
2016
Q2
$2.68M Buy
187,973
+28,854
+18% +$441K ﹤0.01% 2874
2016
Q1
$2.47M Buy
159,119
+1,743
+1% +$25K ﹤0.01% 2847
2015
Q4
$2.71M Buy
157,376
+959
+0.6% +$13.9K ﹤0.01% 2866
2015
Q3
$1.91M Buy
156,417
+89,824
+135% +$1.15M ﹤0.01% 3078
2015
Q2
$803K Buy
66,593
+14,360
+27% +$141K ﹤0.01% 3426
2015
Q1
$437K Sell
52,233
-891
-2% -$6.99K ﹤0.01% 3648
2014
Q4
$406K Sell
53,124
-79
-0.1% -$566 ﹤0.01% 3613
2014
Q3
$366K Buy
53,203
+468
+0.9% +$3.5K ﹤0.01% 3645
2014
Q2
$436K Buy
52,735
+1,078
+2% +$8.43K ﹤0.01% 3634
2014
Q1
$417K Buy
51,657
+6,752
+15% +$54K ﹤0.01% 3586
2013
Q4
$360K Buy
44,905
+4,500
+11% +$34.8K ﹤0.01% 3573
2013
Q3
$271K Buy
40,405
+2,569
+7% +$17.4K ﹤0.01% 3576
2013
Q2
$248K Buy
+37,836
New +$238K ﹤0.01% 3611

Other funds holding LMAT

Northern Trust's LMAT Position: Q1 2026 in Review

Northern Trust reduced its LeMaitre Vascular (LMAT) stake by 2.1% in Q1 2026, selling an estimated $654K and leaving 312,555 shares worth $34.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1357.

Northern Trust first reported a position in LMAT in Q2 2013 and has held it in 52 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Northern Trust held 312,555 shares of LeMaitre Vascular worth $34.1M as of Q1 2026.
  • Northern Trust sold 6,857 LeMaitre Vascular shares in Q1 2026, an estimated $654K.
  • LeMaitre Vascular made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1357 holding.
  • Northern Trust first reported a position in LeMaitre Vascular in Q2 2013 and has held it in 52 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.